<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title xml:lang="eng">Somatic STAT5BN642H mutations shape variable immune landscapes resulting in heterogenous immune diseases</dc:title>
  <dc:description xml:lang="eng">Background

Inborn errors of immunity are traditionally understood as monogenic germline disorders. However, somatic mosaicism can also result in immune-mediated diseases, mimicking inborn errors of immunity. While early postzygotic mosaicism is the predominant mechanism, genetic variants causing a selective advantage to hematopoietic progenitors and/or mature immune cells may cause immune dysregulation and initiate disease at any age. Somatic mosaicism for STAT5BN642H was linked to severe allergic disease in infancy, but its full clinical spectrum and underlying mechanisms remain incompletely defined.

Objective

We elucidated how somatic N642H mutations of the STAT5B gene shape lineage-specific mosaicism, immune cell function, and clinical phenotypes.

Methods

We investigated 3 new patients—including one adult—with STAT5BN642H mosaicism using deep sequencing, flow and mass cytometry, and functional immune assays. Mutant cell distribution was mapped across blood lineages. A mouse model with mosaic STAT5BN642H mutation in hematopoietic stem cells was generated to study clonal dynamics and immune phenotypes.

Results

Patients displayed variable lineage mosaicism correlating with two predominant clinical outcomes: early-onset severe atopy with hypereosinophilia, and autoimmune-lymphoproliferative immunodeficiency with expansions of CD8 and γδ T cells. Functional studies revealed enhanced IL-2–mediated proliferation, effector differentiation, and oligoclonal T-cell expansions. In mice, a few mutant hematopoietic stem cells reproduced the patient lineage-skewed immune landscapes with variable growth advantage of mutant cells across hematopoietic development and recapitulated patient T-cell phenotypes. Targeted mTOR inhibition successfully controlled lymphoproliferation in patients.
Conclusion
A single somatic variant in a few stem cells can remodel hematopoiesis, generating variable immune mosaics and heterogeneous immune disease.</dc:description>
  <dc:type xml:lang="deu">Text</dc:type>
  <dc:type xml:lang="deu">Wissenschaftlicher Artikel</dc:type>
  <dc:rights xml:lang="ita">Open Access</dc:rights>
  <dc:language>eng</dc:language>
  <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
  <dc:format>application/pdf</dc:format>
  <dc:subject xml:lang="eng">STAT5B</dc:subject>
  <dc:subject xml:lang="eng">somatic mosaicism</dc:subject>
  <dc:subject xml:lang="eng">hematopoietic stem cells</dc:subject>
  <dc:subject xml:lang="eng">clonal hematopoiesis</dc:subject>
  <dc:subject xml:lang="eng">immune dysregulation</dc:subject>
  <dc:subject xml:lang="eng">T-cell lymphoproliferation</dc:subject>
  <dc:subject xml:lang="eng">autoimmunity</dc:subject>
  <dc:subject xml:lang="eng">atopy</dc:subject>
  <dc:subject xml:lang="eng">mTOR inhibition</dc:subject>
  <dc:creator>Sarah Grün</dc:creator>
  <dc:creator>Anne Rensing-Ehl</dc:creator>
  <dc:creator>Tobias Suske (University of Veterinary Medicine Vienna)</dc:creator>
  <dc:creator>Julian Wolter-Mess</dc:creator>
  <dc:creator>Jonathan Gehrig</dc:creator>
  <dc:creator>Jasmin Mann</dc:creator>
  <dc:creator>Christoph König</dc:creator>
  <dc:creator>Mathias Hauri</dc:creator>
  <dc:creator>Maximilian Heeg</dc:creator>
  <dc:creator>Timothy Ronan Leahy</dc:creator>
  <dc:creator>David Genevieve</dc:creator>
  <dc:creator>Jean-Baptiste Gaillard</dc:creator>
  <dc:creator>Martin Broly</dc:creator>
  <dc:creator>Arnaud Bourdin</dc:creator>
  <dc:creator>Carla Castro</dc:creator>
  <dc:creator>Lea Seidel</dc:creator>
  <dc:creator>Bertram Bengsch</dc:creator>
  <dc:creator>Peter Aichele</dc:creator>
  <dc:creator>Kristoffer Weißert</dc:creator>
  <dc:creator>Juncal Fernandez-Orth</dc:creator>
  <dc:creator>Vincent Schipperges</dc:creator>
  <dc:creator>Geoffroy Andrieux</dc:creator>
  <dc:creator>Melanie Boerries</dc:creator>
  <dc:creator>Nina Cabezas-Wallscheid</dc:creator>
  <dc:creator>Miriam Erlacher</dc:creator>
  <dc:creator>Roland Elling</dc:creator>
  <dc:creator>Carsten Speckmann</dc:creator>
  <dc:creator>Lara Heller</dc:creator>
  <dc:creator>Björn Schulte</dc:creator>
  <dc:creator>Myriam Lorenz</dc:creator>
  <dc:creator>Klaus Schwarz</dc:creator>
  <dc:creator>Richard Moriggl</dc:creator>
  <dc:creator>Stephan Ehl</dc:creator>
  <dc:publisher>Elsevier</dc:publisher>
  <dc:type xml:lang="ita">Documento PDF</dc:type>
  <dc:type xml:lang="ita">Articolo scientifico</dc:type>
  <dc:identifier>doi:10.1016/j.jaci.2025.12.993</dc:identifier>
  <dc:source xml:lang="eng">Journal of Allergy and Clinical Immunology</dc:source>
  <dc:type xml:lang="eng">Text</dc:type>
  <dc:type xml:lang="eng">journal article</dc:type>
  <dc:rights xml:lang="eng">© 2025 The Authors</dc:rights>
  <dc:rights xml:lang="eng">open access</dc:rights>
  <dc:date>2026</dc:date>
  <dc:identifier>https://phaidra.vetmeduni.ac.at/o:5455</dc:identifier>
</oai_dc:dc>